ADIPOQ and breast cancer: This decrease in fat mass leads to an increase in circulating adiponectin levels while simultaneously reducing several circulating pro-inflammatory adipokines, including IL-6, TNF-α, RBP-4, and leptin [234], many of which are implicated in the development and progression of BC [235].